UPDATE – dSPACE and LeddarTech Join Forces to Deliver Key Tools Enabling Deployment of ADAS and AD Systems

PADERBORN, Germany, and QUEBEC CITY, Canada, Dec. 10, 2020 (GLOBE NEWSWIRE) — dSPACE, one of the world’s leading providers of simulation and validation solutions, and LeddarTech®, a leader in Level 1 to 5 ADAS and AD sensing technology, have entered into a partnership to jointly drive forward the development of LiDAR technologies for Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD). This close cooperation will lead to high-precision simulation tools and models to support and significantly accelerate the development and validation of optimally tailored LeddarEngine™-based LiDAR sensors and related ADAS & AD systems.

These tools enable customers to simulate their own LeddarEngine-based LiDAR sensor designs versus integration of third-party black box LiDARs. Simulation more specifically helps designers efficiently explore various LiDAR sensor architectures and components in development of their own optimal LiDAR design and validate the resulting performance within specific application use cases. This validation includes physically accurate simulation of the LiDAR and the vehicle environment, including objects in motion (e.g., vehicles, pedestrians), the road and other static objects (e.g., traffic signs, curbs).

“The right testing strategy, the right models and ready-to-use interfaces for simulation and reprocessing are key building blocks,” said Dr. Christopher Wiegand, Product Manager at dSPACE. “This partnership with an industry leader in solid-state automotive LiDAR and sensing solutions enables our customers to accurately and quickly perform validation tasks for LiDAR-based applications. Without reliable simulations, automated driving systems (SAE Levels 3-5) cannot be achieved.”

“The collaboration between dSpace and LeddarTech will yield enhanced simulation tools that will greatly ease and accelerate the development of optimized LiDARs,” stated Michael Poulin, Vice-President, Strategic Partnerships and Corporate Development at LeddarTech. “We are delighted to welcome dSpace as a new member of the Leddar Ecosystem, supporting the mass deployment of automotive LiDAR within cost-efficient and safe ADAS & AD systems.”

About
dSPACE

dSPACE is a leading provider of solutions for developing connected, autonomous and electrically powered vehicles. Particularly automotive manufacturers and their suppliers use the company’s end-to-end solution range to test the software and hardware components of their new vehicles long before a new model is allowed on the road. dSPACE is not only a sought-after development partner in vehicle development. Engineers also rely on our dSPACE know-how in aerospace and industrial automation. Our portfolio ranges from end-to-end solutions for simulation and validation to engineering and consulting services as well as training and support. With approximately 1,800 employees worldwide, dSPACE is headquartered in Paderborn, Germany; has three project centers in Germany; and serves customers through regional dSPACE companies in the USA, the UK, France, Japan, China and Croatia.

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision™ sensor-fusion and perception platform and its cost-effective, scalable, and versatile LiDAR development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™, LeddarTech enables Tier 1-2 automotive system integrators to develop full-stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttle, truck, bus, delivery vehicle, smart city/factory, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:

Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
[email protected]

Contact:
dSPACE GmbH dSPACE GmbH
Bernd Schäfers-Maiwald Ulrich Nolte
Vice President Corporate Communications Senior Communications Manager
Rathenaustraße 26 Rathenaustraße 26
33102 Paderborn 33102 Paderborn
Tel: +49 5251 1638-714 Tel.: +49 5251 1638-941
Fax: +49 5251 16198-714 Fax: +49 5251 16198-1448
E-mail: [email protected] E-mail: [email protected], [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e95e1bf-b301-4b74-aea5-ea32de5a39ae



Top Economic and Housing Experts Predict Post-Pandemic Rebound With Continued Job Growth, Stable Interest Rates in 2021

NAR also names its top 10 real estate markets during and in a post-COVID-19 environment

Washington, D.C., Dec. 10, 2020 (GLOBE NEWSWIRE) —

Key Highlights

  • More than 20 leading economic and housing experts predict GDP growth of 3.5% and an annual unemployment rate of 6.2% in 2021.
  • Housing prices are expected to climb 8.0% next year and 5.5% in 2022, with 30-year fixed mortgage rates of 3.0% and 3.25% for 2021 and 2022, respectively.
  • Dallas-Fort Worth, Atlanta, Phoenix, Indianapolis and Provo-Orem join five other metropolitan areas among NAR’s top 10 real estate markets during and in a post-COVID-19 environment.

WASHINGTON (December 10, 2020) – Expect the post-pandemic economic rebound, improving job conditions and stable interest rates to continue in 2021, according to a survey of more than 20 top U.S. economic and housing experts. Lawrence Yun, NAR chief economist and senior vice president of research, unveiled the consensus forecast today during NAR’s second annual Real Estate Forecast Summit.

The group of experts predicted:

  • Gross Domestic Product growth of 3.5% in 2021 and 3.0% in 2022;
  • An annual unemployment rate of 6.2% next year with a decline to 5.0% in 2022;
  • Average annual 30-year fixed mortgage rates of 3.0% and 3.25% for 2021 and 2022, respectively;
  • Annual median home prices to increase by 8.0% in 2021 and by 5.5% in 2022;
  • Housing starts of 1.50 million next year and 1.59 million in 2022;
  • The share of the U.S. workforce working from home to be 18% in 2021 – down from 21% in 2020 – and 12% in 2022; and
  • Small declines in office and hotel vacancy rates in 2021, with a slight increase in retail vacancies next year.

When asked if the Federal Open Market Committee will change the federal funds rate in 2021, 90% of the experts surveyed said they expect no change in the current rate of 0%. For 2022, the experts predict a rate increase of 0.25%.

“It is an understatement to say the year 2020 has been filled with challenges and full of surprises,” said Yun. “Yet, one astonishing development has been the hot housing market as consumers eyed record-low mortgage rates and reconsidered what a home should be in a new economy with flexible work-from-home schedules.”

In 2020, home sales will reach 5.52 million, the highest annual mark since 2006, with the median home price setting a record high of $293,000, according to NAR.

Top 10 Real Estate Markets During and in a Post-COVID-19 Environment

NAR identified 10 markets that have shown resilience during this pandemic period and are expected to perform well in a post-COVID-19 environment in the next two years. In alphabetical order, the markets are:

  • Atlanta-Sandy Springs-Alpharetta, Georgia
  • Boise City, Idaho
  • Charleston-North Charleston, South Carolina
  • Dallas-Fort Worth-Arlington, Texas
  • Des Moines-West Des Moines, Iowa
  • Indianapolis-Carmel-Anderson, Indiana
  • Madison, Wisconsin
  • Phoenix-Mesa-Chandler, Arizona
  • Provo-Orem, Utah
  • Spokane-Spokane Valley, Washington

“Some markets have been performing exceptionally well throughout the pandemic and they’ll likely carry that momentum well into 2021 and beyond because of strong in-migration of new residents, faster local job market recoveries and environments conducive to work-from-home arrangements and other factors,” Yun said.

NAR identified the top 10 metro areas by considering a variety of indicators that it views to be influential to a metro area’s recovery and growth prospects in a post-pandemic environment over the next two years, including: unemployment rate; net domestic migration, including movers from expensive West Coast areas; share of workers in retail trade, leisure and hospitality industries; mobility to retail and leisure places; and the fraction of the workforce working from home, among others.

“As we look towards 2021 and beyond, expect these 10 markets to perform strongly with potential buyers finding conditions particularly favorable to purchase a home,” said NAR President Charlie Oppler, a Realtor® from Franklin Lakes, N.J., and the CEO of Prominent Properties Sotheby’s International Realty. “Overall, residential real estate will continue to be an important driver of our nation’s economic recovery and the activity in these markets will help lead the way.”

Low unemployment rates compared to the national average signaled strong employment environments for residents of these areas. At 4.2%, Provo-Orem boasts the lowest unemployment rate among those listed, followed by Madison at 4.3%, Charleston at 4.7% and Des Moines at 5%.

Areas that are already attractive destinations to purchase a home, especially among movers from more expensive West Coast cities, may attract more technology workers, many of whom are from organizations with very flexible, and in some cases permanent, work-from-home policies. Overall, the Phoenix metro area attracted the largest number of movers from West Coast metro areas, with Dallas ranking second. Atlanta had the highest share of workers working from home at 8.8%, compared to the national share of 5.6%. Spokane also had a high fraction of the workforce work from home at 7.2%.

To view NAR’s Top 10 Markets During and in a Post-COVID-19 Environment report, visit https://www.nar.realtor/reports/top-ten-markets-during-covid.  

The 2020 NAR Real Estate Forecast Summit consensus forecasts are compiled as the median of the responses of 23 economic and housing market experts who participated during the 2019 and 2020 summits. The survey was conducted from November 19 through December 4, 2020.

To view the 2020 NAR Real Estate Forecast Summit consensus forecast report, visit https://www.nar.realtor/research-and-statistics/research-reports/2020-consensus-forecast.  

The National Association of Realtors® is America’s largest trade association, representing more than 1.4 million members involved in all aspects of the residential and commercial real estate industries.

# # #

Information about NAR is available at nar.realtor. This and other news releases are posted in the newsroom at nar.realtor/newsroom.


Troy Green
National Association of Realtors®
202-383-1042
[email protected]

Atlantica Receives A- Rating From CDP

December 10, 2020 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”), the sustainable infrastructure company that owns a diversified portfolio of contracted assets in the energy and environment sectors, has been recognized for its leadership against climate change by top global environmental organization CDP.

CDP is a leading provider of environmental management and transparency and rates more than 9,600 companies. In its 2020 Climate Change assessment, Atlantica received an A-, an increase of one notch compared to its 2019 evaluation. Atlantica was rated higher than the average Renewable Power Generation sector within CDP’s rating universe.

“We are very proud to be recognized by the CDP as a leader in climate change. We believe that Atlantica is leading the transition towards a more sustainable world.” said Santiago Seage, Atlantica’s CEO. He added: “Climate change mitigation is core to our strategy and we will continue focusing on environmental initiatives and transparency.”

About CDP

CDP drives companies and governments to reduce their greenhouse gas emissions, safeguard water resources and protect forests. Voted number one climate research provider by investors and working with institutional investors with assets of US$106 trillion, CDP leverages investor and buyer power to motivate companies to disclose and manage their environmental impacts. Over 9,600 companies with over 50% of global market capitalization disclosed environmental data through CDP in 2020.

About Atlantica

Atlantica Sustainable Infrastructure plc is a sustainable infrastructure company that owns a diversified portfolio of contracted renewable energy, efficient natural gas, electric transmission and water assets in North & South America, and certain markets in EMEA (https://www.atlantica.com/). 

Chief Financial Officer

Francisco Martinez-Davis

E [email protected]

                 

Investor Relations & Communication

Leire Perez

E [email protected]

T +44 20 3499 0465                                   

               



TMX Group, Steppe Gold, C-Suite at The Open

Canada NewsWire

TORONTO, Dec. 10, 2020 /CNW/ – Matthew Wood, Executive Chairman, Steppe Gold Limited (TSX: STGO), shares his company’s story in aninterview with TMX Group.

The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html.


About Steppe Gold Limited (TSX: STGO)

Steppe Gold Ltd. is a precious metals exploration and development company focused on opportunities in Mongolia. The company’s projects include the Altan Tsagaan Ovoo Project (ATO Project) and Uudam Khundii property in Mongolia. For more information visit: https://steppegold.com/ 


About TMX Group (TSX: X)

TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup

SOURCE TMX Group Limited

Michigan Revises Prior Authorization Criteria for Endari®

PR Newswire

TORRANCE, Calif., Dec. 10, 2020 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in the treatment of sickle cell disease, announced today that it was notified by the Michigan Department of Health and Human Services (MDHHS) that the prior authorization criteria for Endari® was revised after being reviewed by Michigan’s Medicaid Health Plan Common Formulary Workgroup. The MDHHS created the common formulary to streamline drug coverage policies for Medicaid and Healthy Michigan Plan beneficiaries and providers.

Effective January 1, 2021, the following two changes will be made regarding the initial authorization of Endari® for the treatment of sickle cell disease: (i) the history of Hydroxyurea use and adherence or intolerance/contraindication to Hydroxyurea will be eliminated from the Endari® initial authorization documentation requirements and (ii) “patient/family refusal” will be added to the existing justifications of intolerance or contraindication to the use of Hydroxyurea.

With this recent revision, MDHHS joins many other state health and human services agencies in eliminating the prior use of Hydroxyurea as a requirement for the initial authorization of Endari® for the treatment of sickle cell disease.

Endari®, Emmaus’ prescription grade L-glutamine oral powder, was approved by the FDA in July 2017 for treating sickle cell disease in adult and pediatric patients five years of age and older. Sales of Endari® began in the United States in 2018.

“We greatly appreciate that the Michigan Department of Health and Human Services has modified the prior authorization criteria for Endari. These revisions, based on review and input from the Medicaid Health Plan Common Formulary Workgroup, will allow Endari to be prescribed to more of Michigan’s sickle cell disease patients, more quickly, than under the current prior authorization criteria,” said Yutaka Niihara, M.D., M.P.H., Chairman and Chief Executive Officer of Emmaus. Dr. Niihara added, “Our goal is to provide Endari to all patients who may benefit from it as promptly as possible.”

About Emmaus Life Sciences
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. For more information, please visit www.emmausmedical.com.

About Endari® (prescription grade L-glutamine oral powder)
Indication – Endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.

Important Safety Information
The most common adverse reactions (incidence >10 percent) in clinical studies were constipation, nausea, headache, abdominal pain, cough, pain in extremities, back pain, and chest pain.

Adverse reactions leading to treatment discontinuation included one case each of hypersplenism, abdominal pain, dyspepsia, burning sensation, and hot flash.

The safety and efficacy of Endari in pediatric patients with sickle cell disease younger than five years of age has not been established.

For more information, please see full Prescribing Information of Endari at: www.EndariRx.com/PI.

About Sickle Cell Disease
Sickle cell disease is an inherited blood disorder characterized by the production of an altered form of hemoglobin which polymerizes and becomes fibrous, causing red blood cells to become rigid and change form so that they appear sickle shaped instead of soft and rounded.  Patients with sickle cell disease suffer from debilitating episodes of sickle cell crises, which occur when the rigid, adhesive and inflexible red blood cells occlude blood vessels.  Sickle cell crises cause excruciating pain as a result of insufficient oxygen being delivered to tissue, referred to as tissue ischemia, and inflammation.  These events may lead to organ damage, stroke, pulmonary complications, skin ulceration, infection and a variety of other adverse outcomes.  Sickle cell disease is a significant unmet medical need, affecting approximately one hundred thousand patients in the U.S. and millions worldwide, the majority of which are of African descent.   An estimated 1-in-365 African American children are born with sickle cell disease.

Forward-looking Statements
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding the potential impact of revisions to the prior authorization criteria for Endari® in Michigan. These forward-looking statements are subject to numerous assumptions, risks and uncertainties which change over time, including uncertainties related to the future sales of Endari® in Michigan, Emmaus’ working capital and ability to carry on its existing operations and obtain needed financing and up-listing of Emmaus’ common stock and other factors previously disclosed in the company’s reports filed with the Securities and Exchange Commission, and actual results may differ materially.  Such forward-looking statements speak only as of the date they are made, and Emmaus assumes no duty to update them, except as may be required by law. 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/michigan-revises-prior-authorization-criteria-for-endari-301190606.html

SOURCE Emmaus Life Sciences, Inc.

DEADLINE ALERT for BABA, BIIB, YY, LRN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

PR Newswire

BENSALEM, Pa., Dec. 10, 2020 /PRNewswire/ — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion. 

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected].

Alibaba
Group Holding Limited (NYSE: BABA)
Class Period: July 20, 2020November 3, 2020
Lead Plaintiff Deadline: January 12, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Ant Group did not meet listing qualifications or disclosure requirements for certain material matters; (2) that certain impending changes in the Fintech regulatory environment would impact Ant Group’s business; (3) that, as a result of the foregoing, Ant Group’s IPO was reasonably likely to be suspended; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Biogen, Inc. (NASDAQ: BIIB
Class Period: October 22, 2019November 6, 2020
Lead Plaintiff Deadline:January 12, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding aducanumab’s effectiveness; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

JOYY Inc. (NASDAQ: YY)
Class Period: April 28, 2016November 18, 2020
Lead Plaintiff Deadline: January 19, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) the majority of users at any given time were bots; (3) the Company utilized these bots to effect a roundtripping scheme that manufactured the false appearance of revenues; (4) the Company overstated its cash reserves; (5) the Company’s acquisition of Bigo was largely contrived to benefit corporate insiders; and (6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.  

K12 Inc. (NYSE: LRN)
Class Period: April 27, 2020September 18, 2020
Lead Plaintiff Deadline: January 19, 2021


Shareholders with $100,000 losses or more are encouraged to contact the firm

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) K12 lacked the technological capabilities, infrastructure, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (2) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer systems; (3) K12 was unable to provide the necessary levels of administrative support and training to teachers, students, and parents; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com

 

Cision View original content:http://www.prnewswire.com/news-releases/deadline-alert-for-baba-biib-yy-lrn-law-offices-of-howard-g-smith-reminds-investors-of-class-actions-on-behalf-of-shareholders-301190624.html

SOURCE Law Offices of Howard G. Smith

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Las Vegas Sands Corp. (LVS)

PR Newswire

LOS ANGELES, Dec. 10, 2020 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 21, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Las Vegas Sands Corp. (“Las Vegas Sands ” or the “Company”) (NYSE: LVS) securities between February 27, 2016 and September 15, 2020, inclusive (the “Class Period”).  

If you suffered a loss on your Las Vegas Sands investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/las-vegas-sands-corp/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On July 19, 2020, Bloomberg reported that Las Vegas Sands had settled a lawsuit brought by a former patron for $6.5 million. The lawsuit against the Company’s casino in Singapore, Marina Bay Sands, alleged that the casino transferred funds from his casino deposit accounts without his approval, which triggered a probe by local authorities. The article reported that the U.S. Department of Justice “is also scrutinizing whether anti-money laundering procedures had been breached in the way the Singapore casino handles high rollers.”

On this news, the Company’s stock price fell $1.41, or approximately 3%, to close at $47.28 per share on July 20, 2020, thereby injuring investors.

Then, on September 16, 2020, Bloomberg reported that Marina Bay Sands “has hired a law firm to conduct a new investigation into employee transfers of more than $1 billion in gamblers’ money to third parties.” The article also stated that Singapore’s Casino Regulatory Authority had identified “weaknesses in [Marina Bay Sands’] casino control measures pertaining to fund transfers.”

On this news, the Company’s stock price fell $2.18 per share, or 4%, to close at $49.67 per share on September 16, 2020, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that weaknesses existed in Marina Bay Sands’ casino control measures pertaining to fund transfers; (2) that the Marina Bay Sands’ casino was consequently prone to illicit fund transfers that implicated, among other issues, the transfer of customer funds to unauthorized persons and potential breaches in the Company’s anti-money laundering procedures; (3) that the foregoing foreseeably increased the risk of litigation against the Company, as well as investigation and increased oversight by regulatory authorities; (4) that Las Vegas Sands had inadequate disclosure controls and procedures; (5) that, consequently, all the foregoing issues were untimely disclosed; and (6) that, as a result, the Company’s public statements were materially false and misleading at all relevant times. 

If you purchased or otherwise acquired Las Vegas Sands securities during the Class Period, you may move the Court no later than December 21, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com.  If you inquire by email please include your mailing address, telephone number and number of shares purchased.  

Follow us for updates on LinkedIn, Twitter, or Facebook.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Cision View original content:http://www.prnewswire.com/news-releases/glancy-prongay–murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-against-las-vegas-sands-corp-lvs-301190625.html

SOURCE Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Turquoise Hill Resources Ltd. (TRQ)

LOS ANGELES, Dec. 10, 2020 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 14, 2020 to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Turquoise Hill Resources Ltd. (“Turquoise Hill” or the “Company”) (NYSE: TRQ) securities between July 17, 2018 and July 31, 2019, inclusive (the “Class Period”).

If you suffered a loss on your Turquoise Hill investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/turquoise-hill-resources-ltd/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On February 26, 2019, the Company announced in a press release that, while “the [Oyu Tolgoi] project cost was expected to remain within the $5.3 billion budget,” a review had determined that “there was an increasingly likely risk of a further delay to sustainable first production beyond Q3‘21.” Turquoise Hill attributed the “likely risk” to productivity setbacks in completing Shaft 2 and “challenging ground conditions that have had a direct impact on the project’s critical path.”

On this news, the Company’s share price fell $0.27, or approximately 13%, to close at $1.83 per share on February 27, 2019, thereby injuring investors.

Then, on July 15, 2019, Turquoise Hill announced that sustainable first production from the underground development of Oyu Tolgoi would now be delayed by another 9 to 21 months until May 2022 to June 2023. The Company also stated that “the development capital spend for the project may increase by $1.2 to $1.9 billion over the $5.3 billion previously disclosed.”

On this news, the Company’s share price fell $0.47, or 44%, to close at $0.60 per share on July 16, 2019, thereby injuring investors further.

Then, on July 31, 2019, after the market closed, Turquoise Hill disclosed that it had taken a $600 million impairment charge and a significant “deferred income tax recognition adjustment” tied to the Oyu Tolgoi project, and that it had suffered a loss in the second quarter.

On this news, the Company’s share price fell $0.05, or over 8%, to close at $0.53 per share on August 1, 2019, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the production of underground development of Oyu Tolgoi was not proceeding as planned; (2) there were substantial undisclosed underground stability problems that called into question the design of the mine and the projected cost and timing of production; (3) Turquoise Hill’s publicly released estimates of the cost, date of completion, and dates for production from the underground mine were not attainable; (4) the development capital required for the underground development of Oyu Tolgoi would cost substantially more than a billion dollars over what Turquoise Hill had represented; (5) Turquoise Hill would require additional financing and/or equity to complete the project; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.   

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Turquoise Hill securities during the Class Period, you may move the Court no later than December 14, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com  
[email protected]



Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Loop Industries, Inc. (LOOP)

LOS ANGELES, Dec. 10, 2020 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 14, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Loop Industries, Inc. (“Loop” or the “Company”) (NASDAQ: LOOP) securities between September 24, 2018 and October 12, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Loop investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your information at https://www.glancylaw.com/cases/loop-industries-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On October 13, 2020, Hindenburg Research published a report alleging, among other things, that “[a] former Loop employee told us that Loop’s scientists, under pressure from CEO Daniel Solomita, were tacitly encouraged to lie about the results of the company’s process internally. We have obtained internal documents and photographs to support their claims.” The report also stated that “Loop’s previous claims of breaking PET down to its base chemicals at a recovery rate of 100% were ‘technically and industrially impossible,’” according to a former employee. Moreover, the report alleged that “Executives from a division of key partner Thyssenkrupp, who Loop entered into a ‘global alliance agreement’ with in December 2018, told us their partnership is on ‘indefinite’ hold and that Loop ‘underestimated’ both costs and complexities of its process.”

On this news, the Company’s stock price fell $3.78, or over 32%, to close at $7.83 per share on October 13, 2020, thereby injuring investors.

Then, on October 16, 2020, after the market closed, Loop disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission (“SEC”) for information “regarding testing, testing results and details of results from [Loop’s] Gen I and Gen II technologies and certain of [its] partnerships and agreements.”

On this news, the Company’s stock price fell as much as 7% in intraday trading on October 19, 2020, the first trading session after the SEC subpoena was disclosed.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Loop scientists were encouraged to misrepresent the results of Loop’s purportedly proprietary process; (2) Loop did not have the technology to break PET down to its base chemicals at a recovery rate of 100%; (3) as a result, Loop was unlikely to realize the purported benefits of Loop’s announced partnerships with Indorama and Thyssenkrupp; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Loop securities during the Class Period, you may move the Court no later than December 14, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles H. Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com  
[email protected]



WSGF – Vaycacychella Generates Flurry Of New Short-Term Rental Property Acquisition Deals And Corresponding Investor Interest Validating $100 Million Revenue Target

PR Newswire

DALLAS, Dec. 10, 2020 /PRNewswire/ — World Series of Golf, Inc. (USOTC: WSGF) (“WSGF”), through its new subsidiary, Vaycaychella, today announced seeing a robust response to recent marketing targeted at finding entrepreneurs looking to acquire and operate short-term vacation property rentals and connecting them with investors. Management indicates the response supports the company’s $100 million revenue target in the first twelve months following the production launch of its peer to peer (P2P) application (app) to fully automate the connection of short-term vacation property buyers with investors.

WSGF acquired Vaycaychella, a sharing economy technology company with a P2P App to connect entrepreneurs seeking to acquire short-term rental vacation properties with investors to back them, earlier this year in January. WSGF is in the process of making a corporate name change in conjunction with its new Vaycaychella business focus.

Vaycaychella is a three-year-old operation that has built a business model focused on financing short-term vacation rental properties outside of conventional financing channels. Vaycaychella’s mission is to empower entrepreneurs looking to get into the short-term vacation property rental business marketed through sharing technology apps such as Airbnb, Booking.com and Vrbo.

Now that Vaycaychella has established a proven model through developing a portfolio of properties that includes 10 Caribbean beach front vacation homes, a boutique hotel, and a recently acquired 3 unit building in Puerto Rico with an overall estimated cumulative value of $12 million, the company is scaling that model with the introduction of a peer-to-peer (P2P) application (App) designed to connect new and existing short-term vacation property rental operators with prospective investors.

To learn more and keep up with the latest updates at Vaycaychella, visit https://www.vaycaychella.com. At the company website, you will find a blog with frequent industry publications on the short-term rental market in general, as well as entries specific to Vaycaychella.

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

WSGF Contact:
William “Bill” Justice
[email protected]
+1 (800) 871-0376

Cision View original content:http://www.prnewswire.com/news-releases/wsgf–vaycacychella-generates-flurry-of-new-short-term-rental-property-acquisition-deals-and-corresponding-investor-interest-validating-100-million-revenue-target-301190627.html

SOURCE World Series of Golf, Inc.